A University of Alberta-led international study could change the standard method of diagnosis for prostate cancer patients, ...
A clinical trial co-led by Yale Urology showed high resolution micro-ultrasound is an effective tool for guiding prostate ...
As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical ...
The MHRA has approved the product for three clinical settings, including identifying how far high-risk prostate cancer has ...
A Scottish masters hockey international has made a remarkable return to the sport, playing in the Over 50s European ...
Blood tests measure the level of PSA protein, produced by the prostate gland, and may help detect early signs of prostate ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
A new international study has shown that a new imaging method called micro-ultrasound (microUS) is just as effective as MRI ...
The FDA expanded the approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and are considered appropriate to ...
These days, a prostate-specific antigen (PSA) blood test is often the first step towards a diagnosis. ‘Men don’t always need ...
Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...
The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results